Data is not available at this time.
Living Platform, Ltd. operates in Japan's healthcare sector, specializing in nursing care, childcare, and disability support services. The company addresses critical societal needs driven by Japan's aging population and increasing demand for care services. Its vertically integrated model allows it to capture value across multiple care segments, positioning it as a regional leader in Sapporo with potential for expansion. Unlike competitors focused solely on elderly care, Living Platform diversifies its revenue streams by catering to childcare and disability support, enhancing resilience against demographic shifts. The company’s localized expertise and government-backed reimbursement frameworks provide stability, though regional concentration may limit near-term scalability. Its asset-light approach in facility management differentiates it from capital-intensive peers, improving operational flexibility.
The company reported revenue of ¥16.66 billion for FY2024, with net income of ¥189 million, reflecting tight margins typical of care-focused businesses. Operating cash flow of ¥1.51 billion suggests adequate liquidity, though capital expenditures of ¥629 million indicate ongoing investments in service capacity. The absence of dividends aligns with reinvestment priorities in a growth-oriented sector.
Diluted EPS of ¥42.39 underscores modest earnings power, constrained by high labor costs inherent to care services. Debt-to-equity metrics are unavailable, but total debt of ¥5.98 billion against ¥1.13 billion in cash highlights leveraged operations. Capital efficiency is likely moderated by regulatory constraints and wage inflation pressures.
Living Platform’s financial health is balanced, with ¥1.13 billion in cash against ¥5.98 billion in total debt, suggesting reliance on financing for growth. The lack of dividend payouts preserves liquidity, but debt servicing may pressure cash flows if revenue growth slows. Sector-specific risks include reimbursement rate changes and labor shortages.
Revenue growth is tied to Japan’s aging demographics, but scalability is limited by regional operations. Zero dividend payouts reflect reinvestment needs. Expansion into adjacent care segments could diversify growth drivers, though execution risks persist. The beta of 0.708 indicates lower volatility relative to the market, typical for defensive healthcare stocks.
At a market cap of ¥4.49 billion, the stock trades at approximately 0.27x revenue, reflecting sector norms for small-cap care providers. Investors likely price in steady but slow growth, given operational constraints. The low beta suggests muted expectations for outsized returns, aligning with the company’s niche positioning.
Living Platform’s multi-service model and regional expertise provide defensive advantages, but national scalability remains untested. Labor cost controls and potential government policy tailwinds could improve margins. Near-term challenges include debt management and geographic expansion, while long-term opportunities lie in Japan’s structural care demand. The outlook remains stable but hinges on operational execution.
Company filings, Tokyo Stock Exchange data
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |